High immunologic risk living donor kidney transplant using bortezomib in a novel induction regimen without acute antibody mediated rejection.

Clinical transplants

Volumn , Issue , 2011, Pages 381-387

  Dunn, T B ^a   Borja Cacho, Daniel ^b   Chinnakotla, Srinath ^b   Finger, Erik ^b   Tamayo, Gerardo ^b   Verghese, Priya ^b   Kim, Youngki ^b   Manivel, Carlos ^b   Kandaswamy, Raja ^b   Matas, Arthur ^b   Pruett, Timothy ^b   Noreen, Harriet ^b   Krefting, Peggy ^b   Maurer, David ^b  

^a UNIVERSITY OF MINNESOTA   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALLOANTIBODY; BORONIC ACID DERIVATIVE; BORTEZOMIB; HLA ANTIGEN; IMMUNOSUPPRESSIVE AGENT; PYRAZINE DERIVATIVE;

ADULT; ARTICLE; BIOPSY; BLOOD; CASE REPORT; CHRONIC KIDNEY FAILURE; COMPUTER ASSISTED TOMOGRAPHY; DESENSITIZATION; DRUG EFFECT; FATALITY; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; HISTOCOMPATIBILITY; HISTOCOMPATIBILITY TEST; HUMAN; IMMUNOLOGICAL MONITORING; IMMUNOLOGY; KIDNEY TRANSPLANTATION; LIVING DONOR; MALE; METHODOLOGY; PHLEBOGRAPHY; RISK ASSESSMENT; RISK FACTOR; TREATMENT OUTCOME;

ADULT; BIOPSY; BORONIC ACIDS; DESENSITIZATION, IMMUNOLOGIC; FATAL OUTCOME; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; HISTOCOMPATIBILITY; HISTOCOMPATIBILITY TESTING; HLA ANTIGENS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; ISOANTIBODIES; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; LIVING DONORS; MALE; MONITORING, IMMUNOLOGIC; PHLEBOGRAPHY; PYRAZINES; RISK ASSESSMENT; RISK FACTORS; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 84864102563     PISSN: 08909016     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)